Skip to content

13F-HR filed by WASHINGTON UNIVERSITY

WASHINGTON UNIVERSITY filed this 13F-HR for the quarter ended 2022-06-30, filed 2022-08-11, with 11 holding rows worth $269,733,000.

Accession
0000903603-22-000004
Filed
2022-08-11
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2022

A holdings report, 11 entries on the cover page, a total value of $269,733,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $269,733,000 with VALUE read as thousands by filing date, 13F file number 028-20724. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LIGHT & WONDER INC COM80874P109Stock1,785,714$83,911,000thousands by filing date
COUPANG INC22266T109CL A6,126,664$78,115,000thousands by filing date
NU HLDGS LTDG6683N103ORD SHS CL A13,938,154$52,129,000thousands by filing date
MODERNA INC60770K107COM150,000$21,428,000thousands by filing date
GUIDEWIRE SOFTWARE INC COM40171V100Stock281,689$19,997,000thousands by filing date
MELI KASZEK PIONEER CORPG5S74L106CLASS A ORD700,000$6,930,000thousands by filing date
VACASA INC91854V107COM1,361,470$3,921,000thousands by filing date
GINKGO BIOWORKS HOLDINGS INC37611X100CL A SHS1,102,044$2,623,000thousands by filing date
NGM BIOPHARMACEUTICALS INC62921N105COM44,314$568,000thousands by filing date
CNFINANCE HLDGS LTD18979T105SPON ADS26,509$68,000thousands by filing date
Mersana Therapeutics Inc59045L106Common Stock9,367$43,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000903603-22-000004this filing2022-08-11acceptance time not in the bulk data set